Trial Profile
An open, prospective, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application in liver transplanted patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Hepatitis B immune globulin (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Registrational; Therapeutic Use
- 13 May 2011 New trial record